Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

BEIGENE, LTD.

(BGNE)
  Report
Delayed Nasdaq  -  04:00:00 2023-02-01 pm EST
254.28 USD   -0.67%
02/01BeiGene to Present at Upcoming Investor Conferences
BU
01/31Beigene, Ltd. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
01/24Morgan Stanley Adjusts Price Target on BeiGene to $325 From $295, Maintains Overweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Analyst Recommendations on BEIGENE, LTD.
01/24Morgan Stanley Adjusts Price Target on BeiGene to $325 From $295, Maintains Overweight ..
MT
01/20Guggenheim Raises Price Target on BeiGene to $350 From $290, Maintains Buy Rating
MT
01/20SVB Securities Adjusts Price Target on BeiGene to $300 From $236, Maintains Outperform ..
MT
2022SVB Securities Adjusts BeiGene Price Target to $236 From $210, Maintains Outperform Rat..
MT
2022SVB Securities Adjusts Price Target on BeiGene to $210 From $200, Maintains Outperform ..
MT
2022Nomura Adjusts BeiGene Price Target to $281.78 From $286.31, Maintains Buy Rating
MT
2022Nomura Adjusts Beigene's Price Target to HK$170.15 From HK$172.89, Keeps at Buy
MT
2022Morgan Stanley Raises BeiGene's Price Target to $295 From $290, Maintains Overweight Ra..
MT
2022Guggenheim Upgrades BeiGene to Buy From Neutral; Price Target is $205
MT
2022SVB Securities Upgrades BeiGene to Outperform From Market Perform, Adjusts Price Target..
MT
2022JPMorgan Assumes BeiGene at Overweight with $296 Price Target
MT
2022Nomura Adjusts BeiGene's Price Target to $286.31 From $277.35, Maintains Buy Rating
MT
2022Nomura Adjusts Beigene's Price Target to HK$172.89 From HK$167.48, Keeps at Buy
MT
2022Analyst recommendations: Eli Lilly, KLA, Kellogg, Epam Systems, ..
MS
2022Nomura Adjusts BeiGene's Price Target to $277.35 From $310.62, Maintains Buy Rating
MT
2022Nomura Adjusts Beigene's Price Target to HK$167.48 From HK$186.85, Keeps at Buy
MT
2022Morgan Stanley Adjusts BeiGene's Price Target to $293 from $300, Keeps Overweight Ratin..
MT
2022Morgan Stanley Adjusts Price Target for BeiGene to $293 From $300, Maintains Overweight..
MT
2022CMB International Starts BeiGene at Buy With $248.52 Price Target
MT
2022Morgan Stanley Lowers BeiGene's Price Target to $300 From $338, Maintains Overweight Ra..
MT
2022Morgan Stanley Adjusts BeiGene's Price Target to $338 from $330, Keeps Overweight Ratin..
MT
2022SVB Leerink Cuts BeiGene to Market Perform From Outperform, Price Target to $177 From $..
MT
2022Nomura Upgrades BeiGene to Buy From Neutral, Adjusts Price Target to $310.62 From $293...
MT
2022Nomura Upgrades BeiGene to Buy From Neutral, Adjusts Price Target to HK$186.85 From HK$..
MT
2022Macquarie Lowers BeiGene's Price Target to $301.60 From $312.80, Maintains Outperform R..
MT
2022Morgan Stanley Lowers BeiGene's Price Target to $330 From $360, Maintains Overweight Ra..
MT
2022Goldman Sachs Lowers BeiGene's Price Target to $364.32 From $410.60, Maintains Buy Rati..
MT
2022SVB Leerink Adjusts BeiGene's Price Target to $300 from $334, Maintains Outperform Rati..
MT
2022Morgan Stanley Adjusts BeiGene's Price Target to $360 from $407, Keeps Overweight Ratin..
MT
2021Nomura Adjusts BeiGene's Price Target to $293.28 From $355.83, Maintains Neutral Rating
MT
2021Nomura Adjusts Beigene's Price Target to HK$176.97 From HK$214.05, Keeps at Neutral
MT
2021Nomura Adjusts BeiGene to Neutral From Not Rated, Sets $355.83 Price Target
MT
2021BeiGene : SVB Leerink Adjusts Price Target on BeiGene to $414 From $417, Maintai..
MT
2021BeiGene : Bernstein Starts BeiGene at Outperform With $431 Price Target
MT
2021BeiGene : Morgan Stanley Adjusts Price Target on BeiGene to $407 From $409, Main..
MT
2021BeiGene : SVB Leerink Adjusts BeiGene's Price Target to $417 from $388, Keeps Ou..
MT
2021BeiGene : Morgan Stanley Adjusts Price Target on BeiGene to $409 From $357, Main..
MT
2021BeiGene : Morgan Stanley Adjusts BeiGene's Price Target to $357 from $375, Keeps..
MT
2021BeiGene : HSBC Adjusts BeiGene's Price Target to $385 from $296, Keeps Buy Ratin..
MT
2021BeiGene : China Renaissance Initiates Coverage on BeiGene With Buy Rating
MT
2021BeiGene : CLSA Downgrades BeiGene to Underperform From Outperform, Adjusts Price..
MT
2021BeiGene : Cowen & Co. Adjusts Price Target on BeiGene to $429 From $348, Maintai..
MT
2021BeiGene : Morgan Stanley Adjusts BeiGene PT to $375 From $310, Maintains Overwei..
MT
2020BeiGene : Ladenburg Thalmann Upgrades BeiGene to Buy From Neutral; Price Target ..
MT
2020BeiGene : SVB Leerink Adjusts BeiGene's Price Target to $327 From $240, Keeps at..
MT
2020BeiGene : Morgan Stanley Adjusts BeiGene PT to $310 From $270, Maintains Overwei..
MT
2020BeiGene : Ladenburg Thalmann Downgrades BeiGene to Neutral from Buy
MT
2020BeiGene : Piper Sandler Downgrades BeiGene to Underweight From Neutral; Price Ta..
MT
Upcoming event on BEIGENE, LTD.